Skip to content

Intervention of Acupoint Application of traditional Chinese medicine on children with functional dyspepsia: a multicenter randomized double-blind placebo-controlled clinical trial

Intervention of Acupoint Application of traditional Chinese medicine on children with functional dyspepsia: a multicenter randomized double-blind placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001314
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia

Interventions

Test group:Kaiwei Zhitong plaste
control group:Appetizer and Pain Relief Patch Simulator

Sponsors

Liaoning University of Traditional Chinese Medicine Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 14 Years

Inclusion criteria

Inclusion criteria: Only those who meet all the following conditions can be selected: (1) It meets the western medicine diagnostic criteria and TCM syndrome diagnostic criteria of FD in children; (2) The age ranged from 1 to 14 years old (= 14 years old) with no sex restriction; (3) Agree to cooperate with the medication and accept the evaluation according to the requirements of the test plan; (4) The informed consent of the legal guardian of the subject must be obtained and the informed consent form must be signed voluntarily; When the subject can make the decision to participate in the clinical trial the consent of the subject must also be obtained. Those who do not meet one of the above conditions shall not be selected as subjects.

Exclusion criteria

Exclusion criteria: Those who meet any of the following criteria shall be excluded: (1) Dyspepsia caused by organic diseases such as acute and chronic gastroenteritis peptic ulcer gastrointestinal surgery history acute and chronic hepatitis anorexia nervosa anorexia caused by some drugs; (2) At the same time the treatment can cause constipation or gastrointestinal motility enhancement; (3) Moderate and severe malnutrition; (4) There are serious primary diseases such as cardiovascular nervous respiratory hepatobiliary and urinary system; (5) Mental intellectual and/or communication disorders; (6) Those who are clearly allergic to the test drug or its preparation ingredients or allergic constitution; (7) Participated in clinical trials in the past 12 weeks; (8) The investigator believes that it is not appropriate to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Total effective rate at 2 weeks after randomization;

Secondary

MeasureTime frame
TCM syndrome efficacy;Nipin Indigestion Index Scale;Changes in Gastric Electrogram;The degree of reduction of the total symptom score each individual symptom score and TCM syndrome score from baseline at each follow-up time point;The disappearance rate and apparent efficiency of individual clinical symptoms;Untargeted metabolomics;Recurrence situation;The number of gut microbiota before and after treatment;Number of days per week with abdominal pain attacks;Gastrointestinal hormone levels;The degree of improvement in weight and eating time;

Countries

China

Contacts

Public ContactWang Xuefeng

Liaoning University of Traditional Chinese Medicine Affiliated Hospital

lnzywxf@163.com13840208807

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026